Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Wave Life Sciences (WVE)

Wave Life Sciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:WVE
DateTimeSourceHeadlineSymbolCompany
27/09/202411:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WVEWave Life Sciences Ltd
26/09/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
26/09/202402:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:WVEWave Life Sciences Ltd
26/09/202402:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:WVEWave Life Sciences Ltd
26/09/202402:14GlobeNewswire Inc.Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:WVEWave Life Sciences Ltd
24/09/202422:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WVEWave Life Sciences Ltd
24/09/202422:13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:WVEWave Life Sciences Ltd
24/09/202421:01GlobeNewswire Inc.Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:WVEWave Life Sciences Ltd
24/09/202412:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
24/09/202412:30GlobeNewswire Inc.Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingNASDAQ:WVEWave Life Sciences Ltd
23/08/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
21/08/202421:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:WVEWave Life Sciences Ltd
14/08/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
14/08/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
14/08/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
12/08/202422:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
12/08/202413:30GlobeNewswire Inc.Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
08/08/202412:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WVEWave Life Sciences Ltd
08/08/202412:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
08/08/202412:30GlobeNewswire Inc.Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
01/08/202413:30GlobeNewswire Inc.Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024NASDAQ:WVEWave Life Sciences Ltd
24/07/202422:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
24/07/202422:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
25/06/202412:30GlobeNewswire Inc.Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s DiseaseNASDAQ:WVEWave Life Sciences Ltd
12/06/202413:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA EditingNASDAQ:WVEWave Life Sciences Ltd
30/05/202413:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 Jefferies Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
10/05/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WVEWave Life Sciences Ltd
09/05/202412:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
09/05/202412:30GlobeNewswire Inc.Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
09/05/202412:00GlobeNewswire Inc.Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific OfficerNASDAQ:WVEWave Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:WVE